APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Nuclear Medicine Diagnostic Equipment

Compare research editions
View pricing & licenses

Selected research

Industry Research

Nuclear Medicine Diagnostic Equipment Industry Research Report 2026

Report ID 173917100525 December 2025136 pages

Choose your research edition.

Industry ResearchNuclear Medicine Diagnostic Equipment Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Nuclear Medicine Diagnostic Equipment Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Nuclear Medicine Diagnostic Equipment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nuclear Medicine Diagnostic Equipment Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Nuclear Medicine Diagnostic Equipment Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Nuclear Medicine Diagnostic Equipment market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Nuclear Medicine Diagnostic Equipment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Nuclear Medicine Diagnostic Equipment is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Nuclear Medicine Diagnostic Equipment is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Nuclear Medicine Diagnostic Equipment include GE HealthCare, Siemens Healthineers, CMR Naviscan, Compañía Mexicana, DDD-Diagnostic, Digirad, Mediso Medical Imaging Systems, Philips and Positron, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Nuclear Medicine Diagnostic Equipment market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Nuclear Medicine Diagnostic Equipment Market by Company

GE HealthCare

Siemens Healthineers

CMR Naviscan

Compañía Mexicana

DDD-Diagnostic

Digirad

Mediso Medical Imaging Systems

Philips

Positron

SurgicEye

TeraRecon

Toshiba

Top Grade Healthcare

Neusoft Group

United Imaging

MinFound Medical

SinoUnion Healthcare

Nuclear Medicine Diagnostic Equipment Segment by Type

PET

SPECT

Nuclear Medicine Diagnostic Equipment Segment by Application

Tumor Imaging

Endocrine System Imaging

Urinary System Imaging

Bone Marrow Imaging

Others

Nuclear Medicine Diagnostic Equipment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclear Medicine Diagnostic Equipment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nuclear Medicine Diagnostic Equipment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nuclear Medicine Diagnostic Equipment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Nuclear Medicine Diagnostic Equipment manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Nuclear Medicine Diagnostic Equipment by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Nuclear Medicine Diagnostic Equipment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Nuclear Medicine Diagnostic Equipment Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Nuclear Medicine Diagnostic Equipment Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Manufacturers (2021-2026) Table 8. Global Nuclear Medicine Diagnostic Equipment Revenue of Manufacturers (2021-2026) Table 9. Global Nuclear Medicine Diagnostic Equipment Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Nuclear Medicine Diagnostic Equipment Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Nuclear Medicine Diagnostic Equipment Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Nuclear Medicine Diagnostic Equipment, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Nuclear Medicine Diagnostic Equipment, Product Type & Application Table 14. Global Nuclear Medicine Diagnostic Equipment Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Nuclear Medicine Diagnostic Equipment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. GE HealthCare Company Information Table 19. GE HealthCare Business Overview Table 20. GE HealthCare Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. GE HealthCare Nuclear Medicine Diagnostic Equipment Product Portfolio Table 22. GE HealthCare Recent Developments Table 23. Siemens Healthineers Company Information Table 24. Siemens Healthineers Business Overview Table 25. Siemens Healthineers Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Siemens Healthineers Nuclear Medicine Diagnostic Equipment Product Portfolio Table 27. Siemens Healthineers Recent Developments Table 28. CMR Naviscan Company Information Table 29. CMR Naviscan Business Overview Table 30. CMR Naviscan Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. CMR Naviscan Nuclear Medicine Diagnostic Equipment Product Portfolio Table 32. CMR Naviscan Recent Developments Table 33. Compañía Mexicana Company Information Table 34. Compañía Mexicana Business Overview Table 35. Compañía Mexicana Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Compañía Mexicana Nuclear Medicine Diagnostic Equipment Product Portfolio Table 37. Compañía Mexicana Recent Developments Table 38. DDD-Diagnostic Company Information Table 39. DDD-Diagnostic Business Overview Table 40. DDD-Diagnostic Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. DDD-Diagnostic Nuclear Medicine Diagnostic Equipment Product Portfolio Table 42. DDD-Diagnostic Recent Developments Table 43. Digirad Company Information Table 44. Digirad Business Overview Table 45. Digirad Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Digirad Nuclear Medicine Diagnostic Equipment Product Portfolio Table 47. Digirad Recent Developments Table 48. Mediso Medical Imaging Systems Company Information Table 49. Mediso Medical Imaging Systems Business Overview Table 50. Mediso Medical Imaging Systems Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Mediso Medical Imaging Systems Nuclear Medicine Diagnostic Equipment Product Portfolio Table 52. Mediso Medical Imaging Systems Recent Developments Table 53. Philips Company Information Table 54. Philips Business Overview Table 55. Philips Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Philips Nuclear Medicine Diagnostic Equipment Product Portfolio Table 57. Philips Recent Developments Table 58. Positron Company Information Table 59. Positron Business Overview Table 60. Positron Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Positron Nuclear Medicine Diagnostic Equipment Product Portfolio Table 62. Positron Recent Developments Table 63. SurgicEye Company Information Table 64. SurgicEye Business Overview Table 65. SurgicEye Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. SurgicEye Nuclear Medicine Diagnostic Equipment Product Portfolio Table 67. SurgicEye Recent Developments Table 68. TeraRecon Company Information Table 69. TeraRecon Business Overview Table 70. TeraRecon Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. TeraRecon Nuclear Medicine Diagnostic Equipment Product Portfolio Table 72. TeraRecon Recent Developments Table 73. Toshiba Company Information Table 74. Toshiba Business Overview Table 75. Toshiba Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Toshiba Nuclear Medicine Diagnostic Equipment Product Portfolio Table 77. Toshiba Recent Developments Table 78. Top Grade Healthcare Company Information Table 79. Top Grade Healthcare Business Overview Table 80. Top Grade Healthcare Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Top Grade Healthcare Nuclear Medicine Diagnostic Equipment Product Portfolio Table 82. Top Grade Healthcare Recent Developments Table 83. Neusoft Group Company Information Table 84. Neusoft Group Business Overview Table 85. Neusoft Group Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Neusoft Group Nuclear Medicine Diagnostic Equipment Product Portfolio Table 87. Neusoft Group Recent Developments Table 88. United Imaging Company Information Table 89. United Imaging Business Overview Table 90. United Imaging Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. United Imaging Nuclear Medicine Diagnostic Equipment Product Portfolio Table 92. United Imaging Recent Developments Table 93. MinFound Medical Company Information Table 94. MinFound Medical Business Overview Table 95. MinFound Medical Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. MinFound Medical Nuclear Medicine Diagnostic Equipment Product Portfolio Table 97. MinFound Medical Recent Developments Table 98. SinoUnion Healthcare Company Information Table 99. SinoUnion Healthcare Business Overview Table 100. SinoUnion Healthcare Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. SinoUnion Healthcare Nuclear Medicine Diagnostic Equipment Product Portfolio Table 102. SinoUnion Healthcare Recent Developments Table 103. Global Nuclear Medicine Diagnostic Equipment Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 104. Global Nuclear Medicine Diagnostic Equipment Sales by Region (2021-2026) & (K Units) Table 105. Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Region (2021-2026) Table 106. Global Nuclear Medicine Diagnostic Equipment Sales by Region (2027-2032) & (K Units) Table 107. Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Region (2027-2032) Table 108. Global Nuclear Medicine Diagnostic Equipment Revenue by Region (2021-2026) & (US$ Million) Table 109. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Region (2021-2026) Table 110. Global Nuclear Medicine Diagnostic Equipment Revenue by Region (2027-2032) & (US$ Million) Table 111. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Region (2027-2032) Table 112. North America Nuclear Medicine Diagnostic Equipment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. North America Nuclear Medicine Diagnostic Equipment Sales by Country (2021-2026) & (K Units) Table 114. North America Nuclear Medicine Diagnostic Equipment Sales by Country (2027-2032) & (K Units) Table 115. North America Nuclear Medicine Diagnostic Equipment Revenue by Country (2021-2026) & (US$ Million) Table 116. North America Nuclear Medicine Diagnostic Equipment Revenue by Country (2027-2032) & (US$ Million) Table 117. Europe Nuclear Medicine Diagnostic Equipment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Europe Nuclear Medicine Diagnostic Equipment Sales by Country (2021-2026) & (K Units) Table 119. Europe Nuclear Medicine Diagnostic Equipment Sales by Country (2027-2032) & (K Units) Table 120. Europe Nuclear Medicine Diagnostic Equipment Revenue by Country (2021-2026) & (US$ Million) Table 121. Europe Nuclear Medicine Diagnostic Equipment Revenue by Country (2027-2032) & (US$ Million) Table 122. Asia Pacific Nuclear Medicine Diagnostic Equipment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Asia Pacific Nuclear Medicine Diagnostic Equipment Sales by Country (2021-2026) & (K Units) Table 124. Asia Pacific Nuclear Medicine Diagnostic Equipment Sales by Country (2027-2032) & (K Units) Table 125. Asia Pacific Nuclear Medicine Diagnostic Equipment Revenue by Country (2021-2026) & (US$ Million) Table 126. Asia Pacific Nuclear Medicine Diagnostic Equipment Revenue by Country (2027-2032) & (US$ Million) Table 127. South America Nuclear Medicine Diagnostic Equipment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. South America Nuclear Medicine Diagnostic Equipment Sales by Country (2021-2026) & (K Units) Table 129. South America Nuclear Medicine Diagnostic Equipment Sales by Country (2027-2032) & (K Units) Table 130. South America Nuclear Medicine Diagnostic Equipment Revenue by Country (2021-2026) & (US$ Million) Table 131. South America Nuclear Medicine Diagnostic Equipment Revenue by Country (2027-2032) & (US$ Million) Table 132. Middle East and Africa Nuclear Medicine Diagnostic Equipment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Middle East and Africa Nuclear Medicine Diagnostic Equipment Sales by Country (2021-2026) & (K Units) Table 134. Middle East and Africa Nuclear Medicine Diagnostic Equipment Sales by Country (2027-2032) & (K Units) Table 135. Middle East and Africa Nuclear Medicine Diagnostic Equipment Revenue by Country (2021-2026) & (US$ Million) Table 136. Middle East and Africa Nuclear Medicine Diagnostic Equipment Revenue by Country (2027-2032) & (US$ Million) Table 137. Global Nuclear Medicine Diagnostic Equipment Sales by Type (2021-2026) & (K Units) Table 138. Global Nuclear Medicine Diagnostic Equipment Sales by Type (2027-2032) & (K Units) Table 139. Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Type (2021-2026) Table 140. Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Type (2027-2032) Table 141. Global Nuclear Medicine Diagnostic Equipment Revenue by Type (2021-2026) & (US$ Million) Table 142. Global Nuclear Medicine Diagnostic Equipment Revenue by Type (2027-2032) & (US$ Million) Table 143. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Type (2021-2026) Table 144. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Type (2027-2032) Table 145. Global Nuclear Medicine Diagnostic Equipment Price by Type (2021-2026) & (US$/Unit) Table 146. Global Nuclear Medicine Diagnostic Equipment Price by Type (2027-2032) & (US$/Unit) Table 147. Global Nuclear Medicine Diagnostic Equipment Sales by Application (2021-2026) & (K Units) Table 148. Global Nuclear Medicine Diagnostic Equipment Sales by Application (2027-2032) & (K Units) Table 149. Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Application (2021-2026) Table 150. Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Application (2027-2032) Table 151. Global Nuclear Medicine Diagnostic Equipment Revenue by Application (2021-2026) & (US$ Million) Table 152. Global Nuclear Medicine Diagnostic Equipment Revenue by Application (2027-2032) & (US$ Million) Table 153. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Application (2021-2026) Table 154. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Application (2027-2032) Table 155. Global Nuclear Medicine Diagnostic Equipment Price by Application (2021-2026) & (US$/Unit) Table 156. Global Nuclear Medicine Diagnostic Equipment Price by Application (2027-2032) & (US$/Unit) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Nuclear Medicine Diagnostic Equipment Distributors List Table 160. Nuclear Medicine Diagnostic Equipment Customers List Table 161. Nuclear Medicine Diagnostic Equipment Industry Trends Table 162. Nuclear Medicine Diagnostic Equipment Industry Drivers Table 163. Nuclear Medicine Diagnostic Equipment Industry Restraints Table 164. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Nuclear Medicine Diagnostic Equipment Product Image Figure 5. Global Nuclear Medicine Diagnostic Equipment Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Nuclear Medicine Diagnostic Equipment Market Size (2021-2032) & (US$ Million) Figure 7. Global Nuclear Medicine Diagnostic Equipment Sales (2021-2032) & (K Units) Figure 8. Global Nuclear Medicine Diagnostic Equipment Average Price (US$/Unit) & (2021-2032) Figure 9. PET Product Image Figure 10. SPECT Product Image Figure 11. Tumor Imaging Product Image Figure 12. Endocrine System Imaging Product Image Figure 13. Urinary System Imaging Product Image Figure 14. Bone Marrow Imaging Product Image Figure 15. Others Product Image Figure 16. Global Nuclear Medicine Diagnostic Equipment Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Nuclear Medicine Diagnostic Equipment, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Nuclear Medicine Diagnostic Equipment Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Nuclear Medicine Diagnostic Equipment Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Nuclear Medicine Diagnostic Equipment Sales by Region in 2025 Figure 22. Global Nuclear Medicine Diagnostic Equipment Revenue by Region in 2025 Figure 23. North America Nuclear Medicine Diagnostic Equipment Market Size by Country in 2025 Figure 24. North America Nuclear Medicine Diagnostic Equipment Sales Market Share by Country (2021-2032) Figure 25. North America Nuclear Medicine Diagnostic Equipment Revenue Market Share by Country (2021-2032) Figure 26. United States Nuclear Medicine Diagnostic Equipment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Nuclear Medicine Diagnostic Equipment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Nuclear Medicine Diagnostic Equipment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Nuclear Medicine Diagnostic Equipment Market Size by Country in 2025 Figure 30. Europe Nuclear Medicine Diagnostic Equipment Sales Market Share by Country (2021-2032) Figure 31. Europe Nuclear Medicine Diagnostic Equipment Revenue Market Share by Country (2021-2032) Figure 32. Germany Nuclear Medicine Diagnostic Equipment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Nuclear Medicine Diagnostic Equipment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Nuclear Medicine Diagnostic Equipment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Nuclear Medicine Diagnostic Equipment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Nuclear Medicine Diagnostic Equipment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Nuclear Medicine Diagnostic Equipment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Nuclear Medicine Diagnostic Equipment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Nuclear Medicine Diagnostic Equipment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Nuclear Medicine Diagnostic Equipment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Nuclear Medicine Diagnostic Equipment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Nuclear Medicine Diagnostic Equipment Market Size by Country in 2025 Figure 43. Asia Pacific Nuclear Medicine Diagnostic Equipment Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Nuclear Medicine Diagnostic Equipment Revenue Market Share by Country (2021-2032) Figure 45. China Nuclear Medicine Diagnostic Equipment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Nuclear Medicine Diagnostic Equipment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Nuclear Medicine Diagnostic Equipment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Nuclear Medicine Diagnostic Equipment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Nuclear Medicine Diagnostic Equipment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Nuclear Medicine Diagnostic Equipment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Nuclear Medicine Diagnostic Equipment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Nuclear Medicine Diagnostic Equipment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Nuclear Medicine Diagnostic Equipment Market Size by Country in 2025 Figure 54. South America Nuclear Medicine Diagnostic Equipment Sales Market Share by Country (2021-2032) Figure 55. South America Nuclear Medicine Diagnostic Equipment Revenue Market Share by Country (2021-2032) Figure 56. Brazil Nuclear Medicine Diagnostic Equipment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Nuclear Medicine Diagnostic Equipment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Nuclear Medicine Diagnostic Equipment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Nuclear Medicine Diagnostic Equipment Market Size by Country in 2025 Figure 60. Middle East and Africa Nuclear Medicine Diagnostic Equipment Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Nuclear Medicine Diagnostic Equipment Revenue Market Share by Country (2021-2032) Figure 62. Egypt Nuclear Medicine Diagnostic Equipment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Nuclear Medicine Diagnostic Equipment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Nuclear Medicine Diagnostic Equipment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Nuclear Medicine Diagnostic Equipment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Nuclear Medicine Diagnostic Equipment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Type (2021-2032) Figure 68. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Type (2021-2032) Figure 69. Global Nuclear Medicine Diagnostic Equipment Price (US$/Unit) by Type (2021-2032) Figure 70. Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Application (2021-2032) Figure 71. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Application (2021-2032) Figure 72. Global Nuclear Medicine Diagnostic Equipment Price (US$/Unit) by Application (2021-2032) Figure 73. Nuclear Medicine Diagnostic Equipment Value Chain Figure 74. Nuclear Medicine Diagnostic Equipment Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Nuclear Medicine Diagnostic Equipment Industry Opportunities and Challenges

Scope & coverage.

Types
  • PET
  • SPECT
Applications
  • Tumor Imaging
  • Endocrine System Imaging
  • Urinary System Imaging
  • Bone Marrow Imaging
  • Others
Companies covered
  • GE HealthCare
  • Siemens Healthineers
  • CMR Naviscan
  • Compañía Mexicana
  • DDD-Diagnostic
  • Digirad
  • Mediso Medical Imaging Systems
  • Philips
  • Positron
  • SurgicEye
  • TeraRecon
  • Toshiba
  • Top Grade Healthcare
  • Neusoft Group
  • United Imaging
  • MinFound Medical
  • SinoUnion Healthcare

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Nuclear Medicine Diagnostic Equipment Market Size (2021-2032)
  4. 2.2.2 Global Nuclear Medicine Diagnostic Equipment Sales (2021-2032)
  5. 2.2.3 Global Nuclear Medicine Diagnostic Equipment Market Average Price (2021-2032)
  6. 2.3 Nuclear Medicine Diagnostic Equipment by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 PET
  9. 2.3.3 SPECT
  10. 2.4 Nuclear Medicine Diagnostic Equipment by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Tumor Imaging
  13. 2.4.3 Endocrine System Imaging
  14. 2.4.4 Urinary System Imaging
  15. 2.4.5 Bone Marrow Imaging
  16. 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Nuclear Medicine Diagnostic Equipment Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Nuclear Medicine Diagnostic Equipment Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Nuclear Medicine Diagnostic Equipment Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Nuclear Medicine Diagnostic Equipment Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Nuclear Medicine Diagnostic Equipment Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Nuclear Medicine Diagnostic Equipment, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Nuclear Medicine Diagnostic Equipment, Product Type & Application
  8. 3.8 Global Manufacturers of Nuclear Medicine Diagnostic Equipment, Established Date
  9. 3.9 Global Nuclear Medicine Diagnostic Equipment Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 GE HealthCare
  2. 4.1.1 GE HealthCare Company Information
  3. 4.1.2 GE HealthCare Business Overview
  4. 4.1.3 GE HealthCare Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 GE HealthCare Nuclear Medicine Diagnostic Equipment Product Portfolio
  6. 4.1.5 GE HealthCare Recent Developments
  7. 4.2 Siemens Healthineers
  8. 4.2.1 Siemens Healthineers Company Information
  9. 4.2.2 Siemens Healthineers Business Overview
  10. 4.2.3 Siemens Healthineers Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Siemens Healthineers Nuclear Medicine Diagnostic Equipment Product Portfolio
  12. 4.2.5 Siemens Healthineers Recent Developments
  13. 4.3 CMR Naviscan
  14. 4.3.1 CMR Naviscan Company Information
  15. 4.3.2 CMR Naviscan Business Overview
  16. 4.3.3 CMR Naviscan Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 CMR Naviscan Nuclear Medicine Diagnostic Equipment Product Portfolio
  18. 4.3.5 CMR Naviscan Recent Developments
  19. 4.4 Compañía Mexicana
  20. 4.4.1 Compañía Mexicana Company Information
  21. 4.4.2 Compañía Mexicana Business Overview
  22. 4.4.3 Compañía Mexicana Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Compañía Mexicana Nuclear Medicine Diagnostic Equipment Product Portfolio
  24. 4.4.5 Compañía Mexicana Recent Developments
  25. 4.5 DDD-Diagnostic
  26. 4.5.1 DDD-Diagnostic Company Information
  27. 4.5.2 DDD-Diagnostic Business Overview
  28. 4.5.3 DDD-Diagnostic Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 DDD-Diagnostic Nuclear Medicine Diagnostic Equipment Product Portfolio
  30. 4.5.5 DDD-Diagnostic Recent Developments
  31. 4.6 Digirad
  32. 4.6.1 Digirad Company Information
  33. 4.6.2 Digirad Business Overview
  34. 4.6.3 Digirad Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Digirad Nuclear Medicine Diagnostic Equipment Product Portfolio
  36. 4.6.5 Digirad Recent Developments
  37. 4.7 Mediso Medical Imaging Systems
  38. 4.7.1 Mediso Medical Imaging Systems Company Information
  39. 4.7.2 Mediso Medical Imaging Systems Business Overview
  40. 4.7.3 Mediso Medical Imaging Systems Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Mediso Medical Imaging Systems Nuclear Medicine Diagnostic Equipment Product Portfolio
  42. 4.7.5 Mediso Medical Imaging Systems Recent Developments
  43. 4.8 Philips
  44. 4.8.1 Philips Company Information
  45. 4.8.2 Philips Business Overview
  46. 4.8.3 Philips Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Philips Nuclear Medicine Diagnostic Equipment Product Portfolio
  48. 4.8.5 Philips Recent Developments
  49. 4.9 Positron
  50. 4.9.1 Positron Company Information
  51. 4.9.2 Positron Business Overview
  52. 4.9.3 Positron Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Positron Nuclear Medicine Diagnostic Equipment Product Portfolio
  54. 4.9.5 Positron Recent Developments
  55. 4.10 SurgicEye
  56. 4.10.1 SurgicEye Company Information
  57. 4.10.2 SurgicEye Business Overview
  58. 4.10.3 SurgicEye Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 SurgicEye Nuclear Medicine Diagnostic Equipment Product Portfolio
  60. 4.10.5 SurgicEye Recent Developments
  61. 4.11 TeraRecon
  62. 4.11.1 TeraRecon Company Information
  63. 4.11.2 TeraRecon Business Overview
  64. 4.11.3 TeraRecon Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 TeraRecon Nuclear Medicine Diagnostic Equipment Product Portfolio
  66. 4.11.5 TeraRecon Recent Developments
  67. 4.12 Toshiba
  68. 4.12.1 Toshiba Company Information
  69. 4.12.2 Toshiba Business Overview
  70. 4.12.3 Toshiba Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Toshiba Nuclear Medicine Diagnostic Equipment Product Portfolio
  72. 4.12.5 Toshiba Recent Developments
  73. 4.13 Top Grade Healthcare
  74. 4.13.1 Top Grade Healthcare Company Information
  75. 4.13.2 Top Grade Healthcare Business Overview
  76. 4.13.3 Top Grade Healthcare Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Top Grade Healthcare Nuclear Medicine Diagnostic Equipment Product Portfolio
  78. 4.13.5 Top Grade Healthcare Recent Developments
  79. 4.14 Neusoft Group
  80. 4.14.1 Neusoft Group Company Information
  81. 4.14.2 Neusoft Group Business Overview
  82. 4.14.3 Neusoft Group Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Neusoft Group Nuclear Medicine Diagnostic Equipment Product Portfolio
  84. 4.14.5 Neusoft Group Recent Developments
  85. 4.15 United Imaging
  86. 4.15.1 United Imaging Company Information
  87. 4.15.2 United Imaging Business Overview
  88. 4.15.3 United Imaging Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 United Imaging Nuclear Medicine Diagnostic Equipment Product Portfolio
  90. 4.15.5 United Imaging Recent Developments
  91. 4.16 MinFound Medical
  92. 4.16.1 MinFound Medical Company Information
  93. 4.16.2 MinFound Medical Business Overview
  94. 4.16.3 MinFound Medical Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 MinFound Medical Nuclear Medicine Diagnostic Equipment Product Portfolio
  96. 4.16.5 MinFound Medical Recent Developments
  97. 4.17 SinoUnion Healthcare
  98. 4.17.1 SinoUnion Healthcare Company Information
  99. 4.17.2 SinoUnion Healthcare Business Overview
  100. 4.17.3 SinoUnion Healthcare Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 SinoUnion Healthcare Nuclear Medicine Diagnostic Equipment Product Portfolio
  102. 4.17.5 SinoUnion Healthcare Recent Developments
5 Global Nuclear Medicine Diagnostic Equipment Market Scenario by Region
  1. 5.1 Global Nuclear Medicine Diagnostic Equipment Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Nuclear Medicine Diagnostic Equipment Sales by Region: 2021-2032
  3. 5.2.1 Global Nuclear Medicine Diagnostic Equipment Sales by Region: 2021-2026
  4. 5.2.2 Global Nuclear Medicine Diagnostic Equipment Sales by Region: 2027-2032
  5. 5.3 Global Nuclear Medicine Diagnostic Equipment Revenue by Region: 2021-2032
  6. 5.3.1 Global Nuclear Medicine Diagnostic Equipment Revenue by Region: 2021-2026
  7. 5.3.2 Global Nuclear Medicine Diagnostic Equipment Revenue by Region: 2027-2032
  8. 5.4 North America Nuclear Medicine Diagnostic Equipment Market Facts & Figures by Country
  9. 5.4.1 North America Nuclear Medicine Diagnostic Equipment Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Nuclear Medicine Diagnostic Equipment Sales by Country (2021-2032)
  11. 5.4.3 North America Nuclear Medicine Diagnostic Equipment Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Nuclear Medicine Diagnostic Equipment Market Facts & Figures by Country
  16. 5.5.1 Europe Nuclear Medicine Diagnostic Equipment Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Nuclear Medicine Diagnostic Equipment Sales by Country (2021-2032)
  18. 5.5.3 Europe Nuclear Medicine Diagnostic Equipment Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Nuclear Medicine Diagnostic Equipment Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Nuclear Medicine Diagnostic Equipment Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Nuclear Medicine Diagnostic Equipment Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Nuclear Medicine Diagnostic Equipment Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Nuclear Medicine Diagnostic Equipment Market Facts & Figures by Country
  41. 5.7.1 South America Nuclear Medicine Diagnostic Equipment Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Nuclear Medicine Diagnostic Equipment Sales by Country (2021-2032)
  43. 5.7.3 South America Nuclear Medicine Diagnostic Equipment Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Nuclear Medicine Diagnostic Equipment Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Nuclear Medicine Diagnostic Equipment Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Nuclear Medicine Diagnostic Equipment Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Nuclear Medicine Diagnostic Equipment Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Nuclear Medicine Diagnostic Equipment Sales by Type (2021-2032)
  2. 6.1.1 Global Nuclear Medicine Diagnostic Equipment Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Type (2021-2032)
  4. 6.2 Global Nuclear Medicine Diagnostic Equipment Revenue by Type (2021-2032)
  5. 6.2.1 Global Nuclear Medicine Diagnostic Equipment Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Nuclear Medicine Diagnostic Equipment Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Nuclear Medicine Diagnostic Equipment Sales by Application (2021-2032)
  2. 7.1.1 Global Nuclear Medicine Diagnostic Equipment Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Application (2021-2032)
  4. 7.2 Global Nuclear Medicine Diagnostic Equipment Revenue by Application (2021-2032)
  5. 7.2.1 Global Nuclear Medicine Diagnostic Equipment Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Nuclear Medicine Diagnostic Equipment Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Nuclear Medicine Diagnostic Equipment Value Chain Analysis
  2. 8.1.1 Nuclear Medicine Diagnostic Equipment Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Nuclear Medicine Diagnostic Equipment Production Mode & Process
  5. 8.2 Nuclear Medicine Diagnostic Equipment Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Nuclear Medicine Diagnostic Equipment Distributors
  8. 8.2.3 Nuclear Medicine Diagnostic Equipment Customers
9 Global Nuclear Medicine Diagnostic Equipment Analyzing Market Dynamics
  1. 9.1 Nuclear Medicine Diagnostic Equipment Industry Trends
  2. 9.2 Nuclear Medicine Diagnostic Equipment Industry Drivers
  3. 9.3 Nuclear Medicine Diagnostic Equipment Industry Opportunities and Challenges
  4. 9.4 Nuclear Medicine Diagnostic Equipment Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst